{ "meta": { "data_length": 1, "message": "Statement id stmt:ema:vectibix:2:0 retrieved successfully", "request_url": "https://api.moalmanac.org/statements?statement_id=stmt%3Aema%3Avectibix%3A2%3A0", "status": "success", "status_code": 200, "timestamp_elapsed": 0.001992, "timestamp_received": "2026-10-16T22:56:06.389140+00:00Z", "timestamp_returned": "2026-10-16T22:56:06.391132+00:00Z", "trace_id": "54828eeb-0526-47b8-8c97-37a21ca7469d" }, "service": { "github": "https://github.com/vanallenlab/moalmanac-db", "name": "Molecular Oncology Almanac", "license": "GPL-2.0", "release": "draft", "url": "https://moalmanac.org", "last_updated": "2026-08-02" }, "data": [ { "id": "stmt:ema:vectibix:2:0", "type": "Statement", "description": "The European Medicines Agency (EMA) has authorized panitumumab as a monotherapy for the treatment of adult patients with wild-type RAS metastatic colorectal cancer (mCRPC) after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens. Panitumumab's product information further states that evidence of wild-type RAS (KRAS and NRAS) status is required before initiating treatment with panitumumab and that mutational status should be deteremined by an experienced laboratory using validated test methods for detection of KRAS (exons 2, 3, and 4) and NRAS (exons 2, 3, and 4) variants.", "contributions": [ { "id": "ctrb:vanallenlab:2024-10-20:0", "type": "Contribution", "description": "Adding EMA approvals for use to database", "date": "2024-10-20", "contributor": { "id": "agent:user:vanallenlab", "type": "Agent", "agentType": "contributor", "name": "Van Allen lab", "description": "Van Allen lab, Dana-Farber Cancer Institute" } }, { "id": "ctrb:ema:2013-07-25:0", "type": "Contribution", "description": "Indication received approval from the European Commission.", "date": "2013-07-25", "contributor": { "id": "agent:org:ema", "type": "Agent", "agentType": "organization", "name": "European Medicines Agency", "description": "Regulatory agency that approves medicines for use in the European Union." } } ], "reportedIn": [ { "id": "doc:ema:vectibix", "type": "Document", "documentType": "Regulatory approval", "name": "Vectibix (panitumumab) [product information]. EMA.", "title": null, "aliases": [], "description": "Amgen Europe B.V. Vectibix (panitumumab) [product information]. European Medicines Agency website. https://www.ema.europa.eu/en/documents/product-information/vectibix-epar-product-information_en.pdf. Revised July 2022. Accessed March 28, 2024.", "urls": [ "https://www.ema.europa.eu/en/documents/product-information/vectibix-epar-product-information_en.pdf", "https://www.ema.europa.eu/en/medicines/human/EPAR/vectibix" ], "doi": null, "pmid": null, "extensions": [ { "name": "agent", "value": { "id": "agent:org:ema", "type": "Agent", "agentType": "organization", "name": "European Medicines Agency", "description": "Regulatory agency that approves medicines for use in the European Union." }, "description": "The organization that published this document." }, { "name": "company", "value": "Amgen Europe B.V.", "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents." }, { "name": "drug_name_brand", "value": "Vectibix", "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents." }, { "name": "drug_name_generic", "value": "panitumumab", "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents." }, { "name": "first_publication_date", "value": "2009-06-18", "description": "The publication date for the initial version of this document." }, { "name": "identification_number", "value": null, "description": "Identification number used by the publishing organization." }, { "name": "publication_date", "value": "2022-07-06", "description": "The publication date for the document." }, { "name": "status", "value": "Active", "description": "Whether this document is Active or Deprecated within moalmanac-db." } ] } ], "direction": "supports", "proposition": { "id": "prop:vtxr:692", "type": "VariantTherapeuticResponseProposition", "predicate": "predictsSensitivityTo", "subjectVariant": { "type": "CategoricalVariant", "description": "Placeholder. Cat-VRS does not yet support sets of categorical variants. See the 'biomarkers' extension for biomarkers associated with this Proposition." }, "conditionQualifier": { "id": "dis:ncit:C5105", "conceptType": "Disease", "name": "Colorectal Adenocarcinoma", "mappings": [ { "relation": "exactMatch", "coding": { "id": "coding:oncotree:COADREAD", "code": "COADREAD", "name": "Colorectal Adenocarcinoma", "system": "https://oncotree.mskcc.org", "systemVersion": "oncotree_2025_10_03", "iris": [ "https://oncotree.mskcc.org/?version=oncotree_2025_10_03&field=NAME&search=Colorectal+Adenocarcinoma+%28COADREAD%29" ] } } ], "extensions": [ { "name": "solid_tumor", "value": true, "description": "Boolean value for if this tumor type is categorized as a solid tumor." } ], "primaryCoding": { "id": "coding:ncit:C5105", "code": "C5105", "name": "Colorectal Adenocarcinoma", "system": "https://evsexplore.semantics.cancer.gov", "systemVersion": "26.08e", "iris": [ "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C5105" ] } }, "objectTherapeutic": { "id": "tx:ncit:C1857", "conceptType": "Therapy", "name": "Panitumumab", "mappings": [ { "relation": "relatedMatch", "coding": { "id": "coding:rxcui:263034", "code": "263034", "name": "panitumumab", "system": "RxNorm", "systemVersion": "02-Mar-2026", "iris": [ "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=263034" ] } }, { "relation": "relatedMatch", "coding": { "id": "coding:omop:19100985", "code": "19100985", "name": "panitumumab", "system": "OMOP", "systemVersion": "v20260227", "iris": [ "https://athena.ohdsi.org/search-terms/terms/19100985" ] } } ], "extensions": [ { "name": "therapy_strategy", "value": [ "EGFR inhibition" ], "description": "Associated therapeutic strategy or mechanism of action of the therapy." }, { "name": "therapy_type", "value": "Targeted therapy", "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types" } ], "primaryCoding": { "id": "coding:ncit:C1857", "code": "C1857", "name": "Panitumumab", "system": "https://evsexplore.semantics.cancer.gov", "systemVersion": "26.08e", "iris": [ "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C1857" ] } }, "extensions": [ { "name": "biomarkers", "value": [ { "id": "bmkr.criterion:25", "present": true, "subject": { "id": "bmkr:25", "type": "CategoricalVariant", "name": "Wild type KRAS", "constraints": [ { "type": "DefiningLocationConstraint", "location": { "id": "ga4gh:SL.fHPHbS6fyaj8MlrRusLFIqH1yXxUPvso", "type": "SequenceLocation", "name": null, "aliases": [], "description": "Sequence spanning the length of refseq:NP_004976.2, the protein product of the MANE Select coding transcript for KRAS (refseq:NM_004985.5).", "digest": "fHPHbS6fyaj8MlrRusLFIqH1yXxUPvso", "sequenceReference": { "id": "ga4gh:SQ.fytWhQSNGnA-86vDiQCxTSzgkk_WfQRS", "type": "SequenceReference", "name": "NP_004976.2", "aliases": [ "ensembl:ENSP00000308495.3", "ga4gh:SQ.fytWhQSNGnA-86vDiQCxTSzgkk_WfQRS", "refseq:NP_004976.2" ], "description": "The protein product of the MANE Select coding transcript for KRAS (refseq:NM_004985.5), corresponding to the Refseq protein accession NP_004976.2.", "moleculeType": "protein", "refgetAccession": "SQ.fytWhQSNGnA-86vDiQCxTSzgkk_WfQRS", "residueAlphabet": "aa" }, "start": 0, "end": 188, "sequence": null }, "relations": [], "matchCharacteristic": { "primaryCoding": { "code": "is_within", "system": "ga4gh-gks-term:location-match" } } }, { "type": "FeatureContextConstraint", "featureContext": { "id": "gene:hgnc:6407", "conceptType": "Gene", "name": "KRAS", "primaryCoding": { "id": "coding:hgnc:6407", "code": "HGNC:6407", "system": "https://genenames.org", "iris": [ "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6407" ] }, "mappings": [ { "relation": "exactMatch", "coding": { "id": "coding:ensembl:ensg00000133703", "code": "ENSG00000133703", "system": "https://www.ensembl.org", "iris": [ "https://www.ensembl.org/id/ENSG00000133703" ] } }, { "relation": "exactMatch", "coding": { "id": "coding:ncbi:3845", "code": "3845", "system": "https://www.ncbi.nlm.nih.gov/gene", "iris": [ "https://www.ncbi.nlm.nih.gov/gene/3845" ] } }, { "relation": "relatedMatch", "coding": { "id": "coding:refseq:NM_004985.5", "code": "NM_004985.5", "system": "https://www.ncbi.nlm.nih.gov/nuccore", "iris": [ "https://www.ncbi.nlm.nih.gov/nuccore/NM_004985.5" ] } } ] } } ], "extensions": [ { "name": "biomarker_type", "value": "Wild type" } ] } }, { "id": "bmkr.criterion:27", "present": true, "subject": { "id": "bmkr:27", "type": "CategoricalVariant", "name": "Wild type NRAS", "constraints": [ { "type": "DefiningLocationConstraint", "location": { "id": "ga4gh:SL.PIDoTr_OYRkt1CZjDo1wtFyVCxYx-VHd", "type": "SequenceLocation", "name": null, "aliases": [], "description": "Sequence spanning the length of refseq:NP_002515.1, the protein product of the MANE Select coding transcript for NRAS (refseq:NM_002524.5).", "digest": "PIDoTr_OYRkt1CZjDo1wtFyVCxYx-VHd", "sequenceReference": { "id": "ga4gh:SQ.974-EgvIQKi6ptqsI6XUZthCv-Py3S18", "type": "SequenceReference", "name": "NP_002515.1", "aliases": [ "ensembl:ENSP00000358548.4", "ga4gh:SQ.974-EgvIQKi6ptqsI6XUZthCv-Py3S18", "refseq:NP_002515.1" ], "description": "The protein product of the MANE Select coding transcript for NRAS (refseq:NM_002524.5), corresponding to the Refseq protein accession NP_002515.1.", "moleculeType": "protein", "refgetAccession": "SQ.974-EgvIQKi6ptqsI6XUZthCv-Py3S18", "residueAlphabet": "aa" }, "start": 0, "end": 189, "sequence": null }, "relations": [], "matchCharacteristic": { "primaryCoding": { "code": "is_within", "system": "ga4gh-gks-term:location-match" } } }, { "type": "FeatureContextConstraint", "featureContext": { "id": "gene:hgnc:7989", "conceptType": "Gene", "name": "NRAS", "primaryCoding": { "id": "coding:hgnc:7989", "code": "HGNC:7989", "system": "https://genenames.org", "iris": [ "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7989" ] }, "mappings": [ { "relation": "exactMatch", "coding": { "id": "coding:ensembl:ensg00000213281", "code": "ENSG00000213281", "system": "https://www.ensembl.org", "iris": [ "https://www.ensembl.org/id/ENSG00000213281" ] } }, { "relation": "exactMatch", "coding": { "id": "coding:ncbi:4893", "code": "4893", "system": "https://www.ncbi.nlm.nih.gov/gene", "iris": [ "https://www.ncbi.nlm.nih.gov/gene/4893" ] } }, { "relation": "relatedMatch", "coding": { "id": "coding:refseq:NM_002524.5", "code": "NM_002524.5", "system": "https://www.ncbi.nlm.nih.gov/nuccore", "iris": [ "https://www.ncbi.nlm.nih.gov/nuccore/NM_002524.5" ] } } ] } } ], "extensions": [ { "name": "biomarker_type", "value": "Wild type" } ] } } ], "description": "The biomarkers associated with this Proposition, each with a `present` flag indicating if the biomarker is present (true) or absent (false). Multiple biomarkers are combined with implied AND logic." } ] }, "strength": { "id": "str:ncit:C25425", "conceptType": "Evidence", "name": "Approval", "mappings": [], "primaryCoding": { "id": "coding:ncit:C25425", "code": "C25425", "name": "Approval", "system": "https://evsexplore.semantics.cancer.gov", "systemVersion": "26.08e", "iris": [ "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25425" ] } }, "extensions": [ { "name": "status", "value": "Active", "description": "Whether this Statement is Active, Superseded, or Deprecated within moalmanac-db." }, { "name": "indication", "value": { "id": "ind:ema:vectibix:2", "type": "Indication", "description": "Vectibix is indicated for the treatment of adult patients with wild-type RAS metastatic colorectal cancer (mCRC) as monotherapy after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.", "contributions": [ { "id": "ctrb:vanallenlab:2024-10-20:0", "type": "Contribution", "description": "Adding EMA approvals for use to database", "date": "2024-10-20", "contributor": { "id": "agent:user:vanallenlab", "type": "Agent", "agentType": "contributor", "name": "Van Allen lab", "description": "Van Allen lab, Dana-Farber Cancer Institute" } }, { "id": "ctrb:ema:2013-07-25:0", "type": "Contribution", "description": "Indication received approval from the European Commission.", "date": "2013-07-25", "contributor": { "id": "agent:org:ema", "type": "Agent", "agentType": "organization", "name": "European Medicines Agency", "description": "Regulatory agency that approves medicines for use in the European Union." } } ], "reportedIn": [ { "id": "doc:ema:vectibix", "type": "Document", "documentType": "Regulatory approval", "name": "Vectibix (panitumumab) [product information]. EMA.", "title": null, "aliases": [], "description": "Amgen Europe B.V. Vectibix (panitumumab) [product information]. European Medicines Agency website. https://www.ema.europa.eu/en/documents/product-information/vectibix-epar-product-information_en.pdf. Revised July 2022. Accessed March 28, 2024.", "urls": [ "https://www.ema.europa.eu/en/documents/product-information/vectibix-epar-product-information_en.pdf", "https://www.ema.europa.eu/en/medicines/human/EPAR/vectibix" ], "doi": null, "pmid": null, "extensions": [ { "name": "agent", "value": { "id": "agent:org:ema", "type": "Agent", "agentType": "organization", "name": "European Medicines Agency", "description": "Regulatory agency that approves medicines for use in the European Union." }, "description": "The organization that published this document." }, { "name": "company", "value": "Amgen Europe B.V.", "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents." }, { "name": "drug_name_brand", "value": "Vectibix", "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents." }, { "name": "drug_name_generic", "value": "panitumumab", "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents." }, { "name": "first_publication_date", "value": "2009-06-18", "description": "The publication date for the initial version of this document." }, { "name": "identification_number", "value": null, "description": "Identification number used by the publishing organization." }, { "name": "publication_date", "value": "2022-07-06", "description": "The publication date for the document." }, { "name": "status", "value": "Active", "description": "Whether this document is Active or Deprecated within moalmanac-db." } ] } ], "extensions": [ { "name": "status", "value": "Approved", "description": "Current approval status." } ] }, "description": "The underlying Indication supporting this Statement." } ] } ] }